Holen Sie sich die Stockscreener-App
16.54
2.19%
-0.37
Handel nachbörslich:
16.45
-0.09
-0.54%
Schlusskurs vom Vortag:
$16.91
Offen:
$16.74
24-Stunden-Volumen:
707.85K
Relative Volume:
0.42
Marktkapitalisierung:
$1.65B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-115.88M
KGV:
-10.69
EPS:
-1.5468
Netto-Cashflow:
$-104.72M
1W Leistung:
+5.48%
1M Leistung:
+43.70%
6M Leistung:
-53.98%
1J Leistung:
-15.27%
1-Tages-Spanne:
$16.30
$16.91
1-Wochen-Bereich:
$14.90
$17.30
52-Wochen-Spanne:
$10.60
$38.12
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Firmenname
Edgewise Therapeutics Inc
Sektor
Branche
Telefon
720-262-7002
Adresse
1715 38TH ST, BOULDER
Vergleichen Sie EWTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
16.54 | 1.65B | 0 | -115.88M | -104.72M | -1.5468 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-30 | Eingeleitet | Guggenheim | Buy |
| 2025-04-02 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-01-22 | Eingeleitet | Stifel | Hold |
| 2024-11-22 | Eingeleitet | Evercore ISI | Outperform |
| 2024-03-07 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-01 | Eingeleitet | Truist | Buy |
| 2022-08-25 | Herabstufung | Goldman | Neutral → Sell |
| 2022-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-01-28 | Eingeleitet | Goldman | Neutral |
Alle ansehen
Edgewise Therapeutics Inc Aktie (EWTX) Neueste Nachrichten
Edgewise Therapeutics (NASDAQ:EWTX) Now Covered by Guggenheim - MarketBeat
Voya Investment Management LLC Lowers Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Is Edgewise Therapeutics, Inc. (EWTX) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - Insider Monkey
Adage Capital Partners GP L.L.C. Purchases 218,491 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Marshall Wace LLP Sells 547,672 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by Schonfeld Strategic Advisors LLC - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by Ally Bridge Group NY LLC - MarketBeat
Acuta Capital Partners LLC Raises Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Invesco Ltd. Reduces Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Foresite Capital Management VI LLC Buys New Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Top 11 Small Cap Stocks to Buy with Biggest Upside Potential - Insider Monkey
Novo Holdings A S Sells 549,900 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (EWTX) Expected to Announce Earnings on Thursday - MarketBeat
First Light Asset Management LLC Purchases Shares of 780,639 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Why Edgewise Therapeutics Stock Popped This Week - The Globe and Mail
Edgewise Therapeutics (EWTX) Initiated at Buy by Guggenheim, Pot - GuruFocus
Edgewise a new buy at Guggenheim on two pipeline prospects - Seeking Alpha
Edgewise Therapeutics (EWTX) Receives Positive Coverage with Str - GuruFocus
Guggenheim Starts Edgewise Therapeutics With Buy Rating, $41 Price Target - marketscreener.com
79,381 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Bought by Harvest Investment Services LLC - MarketBeat
JPMorgan Chase & Co. Sells 34,071 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Russell Investments Group Ltd. Makes New $883,000 Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics' (EWTX) Outperform Rating Reaffirmed at Wedbush - MarketBeat
Analysts Set Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Price Target at $40.38 - MarketBeat
Is Edgewise Therapeutics Inc. (NASDAQ:EWTX) the Most Promising Small-Cap Stock According to Analysts? - Insider Monkey
Jump Financial LLC Sells 76,628 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by Walleye Capital LLC - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Up 9.4%Still a Buy? - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by EAM Investors LLC - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by New Leaf Venture Partners L.L.C. - MarketBeat
Norges Bank Acquires New Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
(EWTX) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Trexquant Investment LP Invests $2 Million in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 52-Week LowHere's What Happened - MarketBeat
Finanzdaten der Edgewise Therapeutics Inc-Aktie (EWTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
3.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):